Lv6
2190 积分 2022-03-21 加入
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial
4天前
已完结
Discovery and optimization of a pH-responsive ultra-long-acting VHH-based growth hormone mimetic
10天前
已关闭
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
14天前
已完结
It Takes Two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease
14天前
已完结
Prevention and Treatment of Peanut Allergy
15天前
已完结
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
16天前
已完结
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
18天前
已完结
Immunoediting restricts clonal neoantigens in primary, treatment-naive human tumors
25天前
已关闭
Antibody-drug conjugates in precision oncology
25天前
已完结
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
29天前
已完结
皖公网安备34019202002308
